THE PURPOSE OF THIS AGREEMENT IS TO FUND RESEARCH SUPPORTING THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) BIOLOGICAL TECHNOLOGIES OFFICES (BTOS) HARNESSING ENZYMATIC ACTIVITY FOR LIFESAVING REDMEDIES (HEALR) PROGRAM. THIS EFFORT SHALL BE CARRIED OUT GENERALLY AS SET FORTH IN EXHIBIT B, RESEARCH DESCRIPTION DOCUMENT, DATED OCTOBER 11, 2022, AND IN THE RECIPIENTS PROPOSAL TITLED, DEVELOPING SIDTACS TO NEUTRALIZE PATHOGENIC TOXINS, DATED APRIL 20, 2022, COPIES OF WHICH ARE IN THE POSSESSION OF BOTH PARTIES.